1
|
Deng Y, Ma L, Du Z, Ma H, Xia Y, Ping L, Chen Z, Zhang Y. The Notch1/Hes1 pathway regulates Neuregulin 1/ErbB4 and participates in microglial activation in rats with VPA-induced autism. Prog Neuropsychopharmacol Biol Psychiatry 2024; 131:110947. [PMID: 38242426 DOI: 10.1016/j.pnpbp.2024.110947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/13/2023] [Revised: 01/08/2024] [Accepted: 01/16/2024] [Indexed: 01/21/2024]
Abstract
The core clinical characteristics of autism, which is a neurodevelopmental disease, involve repetitive behavior and impaired social interactions. Studies have shown that the Notch and Neuregulin1 (NRG1) signaling pathways are abnormally activated in autism, but the mechanism by which these two signaling pathways interact to contribute to the progression of autism has not been determined. Our results suggest that the levels of Notch1, Hes1, NRG1, and phosphorylated ErbB4 in the cerebellum (CB), hippocampus (HC), and prefrontal cortex (PFC) were increased in rats with valproic acid (VPA)-induced autism compared to those in the Con group. However, 3, 5-difluorophenyl-L-alanyl-L-2-phenylglycine tert-butyl (DAPT), which is a Notch pathway inhibitor, ameliorated autism-like behavioral abnormalities and decreased the protein levels of NRG1 and phosphorylated ErbB4 in rats with VPA-induced autism; these results demonstrated that the Notch1/Hes1 pathway could participate in the pathogenesis of autism by regulating the NRG1/ErbB4 signaling pathway. Studies have shown that the Notch pathway regulates microglial differentiation and activation during the onset of neurological disorders and that microglia affect autism-like behavior via synaptic pruning. Therefore, we hypothesized that the Notch1/Hes1 pathway could regulate the NRG1/ErbB4 pathway and thus participate in the development of autism by regulating microglial functions. The present study showed that AG1478, which is an ErbB4 inhibitor, ameliorated the autism-like behaviors in a VPA-induced autism rat model, reduced abnormal microglial activation, and decreased NRG1 and Iba-1 colocalization; however, AG1478 did not alter Notch1/Hes1 activity. These results demonstrated that Notch1/Hes1 may participate in the microglial activation in autism by regulating NRG1/ErbB4, revealing a new mechanism underlying the pathogenesis of autism.
Collapse
Affiliation(s)
- Yanan Deng
- Department of Human Anatomy & Histoembryology, School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, China; Xinxiang Key Laboratory of Molecular Neurology, Xinxiang, Henan 453003, China
| | - Liping Ma
- Department of Human Anatomy & Histoembryology, School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, China; Xinxiang Key Laboratory of Molecular Neurology, Xinxiang, Henan 453003, China
| | - Ziwei Du
- Department of Human Anatomy & Histoembryology, School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, China; Xinxiang Key Laboratory of Molecular Neurology, Xinxiang, Henan 453003, China
| | - Huixin Ma
- Department of Human Anatomy & Histoembryology, School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, China; Xinxiang Key Laboratory of Molecular Neurology, Xinxiang, Henan 453003, China
| | - Yuxi Xia
- Department of Human Anatomy & Histoembryology, School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, China; Xinxiang Key Laboratory of Molecular Neurology, Xinxiang, Henan 453003, China
| | - Liran Ping
- Department of Human Anatomy & Histoembryology, School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, China; Xinxiang Key Laboratory of Molecular Neurology, Xinxiang, Henan 453003, China
| | - Zhaoxing Chen
- Department of Human Anatomy & Histoembryology, School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, China; Xinxiang Key Laboratory of Molecular Neurology, Xinxiang, Henan 453003, China
| | - Yinghua Zhang
- Department of Human Anatomy & Histoembryology, School of Basic Medicine, Xinxiang Medical University, Xinxiang, Henan 453003, China; Xinxiang Key Laboratory of Molecular Neurology, Xinxiang, Henan 453003, China.
| |
Collapse
|
2
|
Chang JC, Lai MC, Chien YL, Cheng CY, Wu YY, Gau SSF. Psychometric properties of the Mandarin version of the autism diagnostic observation Schedule-Generic. J Formos Med Assoc 2023:S0929-6646(23)00008-6. [PMID: 36732136 DOI: 10.1016/j.jfma.2023.01.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2022] [Revised: 12/16/2022] [Accepted: 01/17/2023] [Indexed: 02/01/2023] Open
Abstract
BACKGROUND/PURPOSE The diagnosis of autism spectrum disorder (ASD), involving multiple components of clinical assessments, is challenging. The Autism Diagnostic Observation Schedule-Generic (ADOS-G), one of the standardized and validated instruments for ASD diagnostic evaluation, has been widely used in many countries. With the preparation of the Mandarin version of the ADOS-G (Mandarin-ADOS-G), this study aims to examine its psychometric properties, including reliability and validity. METHODS The sample included 554 individuals clinically diagnosed with ASD (477 males, 86.1%) and 50 typically developing (TD) individuals (29 males, 58.0%) who were assessed with different modules of the Mandarin-ADOS-G between 4.1 and 34.0 years old with a mean age of 13.0 years (Module 1, n = 40; Module 2, n = 46; Module 3, n = 275; Module 4, n = 243). We evaluated the inter-rater reliability, test-retest reliability, internal consistency, and concurrent validity with the Chinese Autism Diagnostic Interview-Revised (ADI-R) and Social Responsiveness Scale (SRS) caregiver-report and self-report forms. The discriminative validity of Mandarin-ADOS-G was also examined. RESULTS The Mandarin-ADOS-G demonstrated good inter-rater reliability (agreement of ADOS classification 0.91), good test-retest reliability (intraclass correlations 0.55-0.73), and low to high good internal consistency (Cronbach's alpha 0.27-0.86). The concurrent validity showed significant correlations with ADI-R (Pearson correlations 0.22-0.37) and the SRS caregiver-report form (Pearson correlations 0.15-0.23). Moreover, all Mandarin-ADOS-G domains successfully differentiated autistic individuals from TD individuals (all p-values <0.001). CONCLUSION The Mandarin-ADOS-G is a reliable and valid instrument for assisting the diagnosis of ASD in the Mandarin-speaking population.
Collapse
Affiliation(s)
- Jung-Chi Chang
- Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
| | - Meng-Chuan Lai
- Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan; The Margaret and Wallace McCain Centre for Child, Youth & Family Mental Health and Azrieli Adult Neurodevelopmental Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada; Department of Psychiatry and Autism Research Unit, The Hospital for Sick Children, Toronto, Canada; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada; Autism Research Centre, Department of Psychiatry, University of Cambridge, Cambridge, UK
| | - Yi-Ling Chien
- Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan
| | - Chung-Yuan Cheng
- Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan; Institute of Biomedical Informatics, National Yang-Ming University, Taipei, Taiwan
| | - Yu-Yu Wu
- YuNing Psychiatric Clinic, Taipei, Taiwan
| | - Susan Shur-Fen Gau
- Department of Psychiatry, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
| |
Collapse
|